HFSA 2018: Underuse of Angiotensin Receptor-Neprilysin Inhibitors for Heart Failure Is Not Due to Financial Barriers
Factors related to finances/insurance do not account for most underutilization of angiotensin receptor-neprilysin inhibition.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.